Forecast: Diabetes Medicine Use in Italy

From 2013 to 2023, the usage of diabetes medicine in Italy has shown a consistent upward trend, rising from 62.4 units to 68.0 units per thousand persons per day. Despite minor fluctuations, the year-on-year variations have generally been positive, with an annual increase of 1.19% in 2023. The average annual growth rate (CAGR) over the last five years up to 2023 stands at 1.54%, reflecting a growing dependency on diabetes medication.

Looking ahead, forecast data suggests that the increase in diabetes medicine use will continue, reaching 74.0 units by 2028. The forecasted average annual growth rate (CAGR) over the next five years is expected to be around 1.35%, with an overall growth rate of 6.94% by 2028.

Future trends to watch for include the impact of new drug developments, changes in healthcare policies, and the integration of digital health technologies along with lifestyle and dietary changes, as they could potentially influence the rate and pattern of diabetes medication usage.